Burkitt's lymphoma in Africa, a review of the epidemiology and etiology

African Health Sciences

Volumn 7, Issue 3, 2007, Pages 166-175

  Orem, Jackson ^a,b   Mbidde, Edward Katongole ^a   Lambert, Bo ^b   De Sanjose, Silvia ^c   Weiderpass, Elisabete ^b,d  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGED; BURKITT LYMPHOMA; CHILD; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; REVIEW;

ADOLESCENT; ADULT; AFRICA; AGED; AGED, 80 AND OVER; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED;

EID: 58149102306     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958;46: 218-23.
2. Burkitt D, O'Conor GT. Malignant lymphoma in African children. I. A clinical syndrome. Cancer 1961;14: 258-69.
3. Bouffet E, Frappaz D, Pinkerton R, Favrot M, Philip. Burkitt's lymphoma: a model for clinical oncology. Eur J Cancer 1991;27: 504-9.
4. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARCPress; 2001.
5. Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H, et al. Cancer in Africa. IARC Scientific Publications No.153. Lyon: IARCPress; 2003.
6. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARCPress; 2004.
7. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000;82: 1585-92.
8. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004;10: 803-21.
9. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4: 757-68.
10. Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002;2: 764-76.
11. Blum W, Mrozek K, Ruppert AS, Carroll AJ, Rao KW, Pettnati MJ, et al. Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature. Cancer 2004;101: 1420-7.
12. Henle W, Diehl V, Kohn G, Zur Hausen H, Henle G. Herpestype virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 1967;157: 1064-5.
13. Henle G, W Henle, Klein G, Gunven P, Clifford P, Morrow RH, et al. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. J Natl Cancer Inst 1971;46: 861-71.
14. Henle, W, Henle G, Klein G, Gunven P, Clifford P, Singh S. Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors. J Natl Cancer Inst 1973;50: 1163-73.
15. Zur Hausen H, Henle W, Hummeler K, Diehl V, Henle G. Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol. 1967;1: 830-7.
16. de-The G, Day NE, Geser A, Lavoue MF, Ho JH, Simons MJ, et al. Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review. IARC Sci Publ 1975;(11 Pt 2): 3-16.
17. Lazzi S, Ferrari F, Nyongo A, Palummo N, de Milito A, Zazzi M, et al. HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 1998;29: 1285-9.
18. Geser A, de The G, Lenoir G, Day NE, Williams EH. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer 1982;29: 397-400.
19. zur Hausen H. Viruses in human cancers. Eur J Cancer 1999;35: 1878-85.
20. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Vol. 70. Lyon: IARC; 1997.
21. Araujo I, Foss HD, Bittencourt A, Hummel M, Demel G, Mendonca N, et al. Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil. Blood 1996;87: 5279-86.
22. Rochford R, Cannon MJ, Moormann AM. Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol 2005;3: 182-7.
23. van den Bosch CA. Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol 2004;5: 738-46.
24. Geser A, Brubaker G, Draper CC. Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am J Epidemiol 1989;129: 740-52.
25. Biggar RJ, Rabkin CS. The epidemiology of acquired immunodeficiency syndrome-related lymphomas. Curr Opin Oncol 1992;4: 883-93.
26. Franceschi S, Dal Maso L, La Vecchia C. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer 1999;83: 481-5.
27. Newton R, Grulich A, Beral V, Sindikubwabo B, Ngilimana PJ, Nganyira A, et al. Cancer and HIV infection in Rwanda. Lancet 1995;345: 1378-9.
28. Sitas F, Pacella-Norman R, Carrera H, Patel M, Ruff P, Sur R, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 2000;88: 489-92.
29. Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katangole-Mbidde E, Wabinga H, Ziegler J. Non-Hodgkin lymphoma in Uganda: a case-control study. Aids 2000;14: 2929-36.
30. Mbidde EK, Banura C, Kazura J, Desmond-Hellmann SD, Kizito A, Hellmann N. NHL and HIV infection in Uganda. 5TH International Conference in Africa on AIDS; 1990.
31. Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H. Uganda Kaposi's Sarcoma Study Group. A casecontrol study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 2001;92: 622-7.
32. Magrath IT. African Burkitt's lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol 1991;13: 222-46.
33. Otieno MW, Remick SC, Whalen C. Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya. Int J Cancer 2001;92: 687-91.
34. Parkin DM, Wabinga H, Nambooze S, Wabwire-Mangen F. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. Aids 1999;13: 2563-70.
35. Daniel E. Burkitt's lymphoma in Ethiopian children. Trop Geogr Med 1990;42: 255-60.
36. Magrath I, Jain V, Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol 1992;3: 285-95.
37. Okpala IE, Akang EE, Okpala UJ. Lymphomas in University College Hospital, Ibadan, Nigeria. Cancer 1991;68: 1356-60.
38. Obafunwa JO, Akinsete I. Malignant lymphomas in Jos, Nigeria: a ten-year study. Cent Afr J Med 1992;38: 17-25.
39. Biggar RJ, Gardiner C, Lennette ET, Collins WE, Nkrumah FK, Henle W. Malaria, sex, and place of residence as factors in antibody response to Epstein-Barr virus in Ghana, West Africa. Lancet 1981;2: 115-8.
40. Mizuno F, Koizumi S, Osato K, Kokwaro JO, Ito Y. Chinese and African Euphorbiaceae plant extracts: markedly enhancing effect on Epstein-Barr virus-induced transformation. Cancer Lett 1983;19: 199-205.
41. Yamamoto N, zur Hausen H. Tumour promoter TPA enhances transformation of human leukocytes by Epstein-Barr virus. Nature 1979;280: 244-5.
42. Baumann M., Mischak H, Dammeier S, Kolch W, Gires O, Pich D, et al. Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation. J Virol 1998;72: 8105-14.
43. MacNeil A, Sumba OP, Lutzke ML, Moormann A, Rochford R. Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br J Cancer 2003;88: 1566-9.
44. Osato T, Mizuno F, Imai S, Aya T, Koizumi S, Kinoshita T, et al. African Burkitt's lymphoma and an Epstein-Barr virusenhancing plant Euphorbia tirucalli. Lancet 1987;1: 1257-8.
45. Neuwinger HD. Plants used for poison fishing in tropical Africa. Toxicon 2004;44: 417-30.
46. Aya T, Kinoshita T, Imai S, Koizumi S, Mizuno F, Osato T. Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes. Lancet 1991; 337: 1190.
47. van den Bosch C, Griffin BE, Kazembe P, Dziweni C, Kadzamira L. Are plant factors a missing link in the evolution of endemic Burkitt's lymphoma? Br J Cancer 1993;68: 1232-5.
48. Kakudidi EK. Cultural and social uses of plants from and around Kibale national Park, Western Uganda. Afr J Ecol 2004;42(Suppl 1): 114-118.
49. Tabuti JR, Dhillion SS, Lye KA. Ethnoveterinary medicines for cattle (Bos indicus) in Bulamogi county, Uganda: plant species and mode of use. J Ethnopharmacol 2003;88: 279-86.
50. Tabuti JR, Lye KA, Dhillion SS. Traditional herbal drugs of Bulamogi, Uganda: plants, use and administration. J Ethnopharmacol 2003;88: 19-44.